Skip to main content
Premium Trial:

Request an Annual Quote

Seryx Licenses Pharmacogenetics Technology to Asian Joint Venture

NEW YORK, Feb. 6 (GenomeWeb News) - Bioinformatics company Seryx has licensed its pharmacogenetics technology to an Asian joint venture, the company said yesterday.


Under the agreement, Singapore-based Seryx Asia, which is owned by both Seryx and Iprex Asia Pacific, obtains the exclusive right to commercialize Seryx's technology in Thailand, Singapore, Hong Kong, Malaysia, Australia, and New Zealand.


Seryx, based in Cherry Hill, NJ, offers genetic and medical history analysis.


The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.